Advisory Research’s Chemours CC Stock Holding History

Advisory Research’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,000	Closed	-$577K	–	435
2017 Q1	$577K	Buy	+15,000	New	+$451K	0.01%	352
2016 Q2	–	Sell	-32,100	Closed	-$225K	–	254
2016 Q1	$225K	Buy	+32,100	New	+$161K	﹤0.01%	249

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Advisory Research's CC Position: Q2 2017 in Review

Advisory Research sold out of Chemours (CC) in Q2 2017, closing a stake of 15,000 shares — an estimated $577K sold.

Advisory Research first reported a position in CC in Q1 2016 and held it in 2 quarters. The position peaked at $577K in Q1 2017. 463 funds tracked by Wall St. Rank hold CC as of Q2 2017.

Advisory Research reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
Advisory Research sold 15,000 Chemours shares in Q2 2017, an estimated $577K.
Advisory Research first reported a position in Chemours in Q1 2016 and held it in 2 quarters.
Advisory Research's Chemours position peaked at $577K in Q1 2017.
463 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on Advisory Research's 13F filing for Q2 2017, filed 14 Aug 2017.